The inaugural Summit was held in 2007 and laid the foundations for the development of the leading Summits of their kind, pioneering the effort to ensure that world class innovation is applied and brought to the market for the benefit of society. The TTS Global Initiative is the key community platform which focuses directly on dialogue, partnering, licensing and technology transfer between public sector biotech research TTOs, early stage start-ups, SMEs and senior industry licensing and business development executives.
The TTS Global Initiative was founded to meet an increasing need for a better understanding between all the stakeholders in the Biotechnology community on the critical need for efficient transfer of early innovative research to commercialisable product technology. The TTS Global Initiative has become a premier international think-tank, community and platform for Technology Transfer professionals, early stage start-ups, C-Level Biotech & SME Executives, Pharma R&D, sourcing, licensing and business development executives, Government funding bodies, VCs, financiers and financial service providers and the legal profession in the biotechnology and life sciences sectors. Bringing together academia, industry and entrepreneurs with leading international experts and practitioners in technology transfer, IP and licensing, TTS Ltd´s summits provide an un-matched environment for fostering increased and improved biotech innovation, technology transfer, licensing, partnering and business development, making sure that the true potential of world-class research is achieved. No other event offers such a high quality mix of senior biotech and Industry stakeholders.
Big Pharma, Biotech and industrial-based companies in the chemical and agricultural industries are looking to create and secure innovative deals with universities, research institutes and early-stage and emerging biotech companies at realistic valuations. The sector as a whole requires innovation and new and improved models and collaborations like never before. Understanding knowledge and delivering access to global connections that enable the transfer of valuable and sought-after technology is a pre-requisite for TTS Ltd. For scientists, universities and research institutes, there is also a responsibility to ensure that publicly funded science generates world class results, which are applied so that society is able to benefit. Smart, effective approaches to innovation and bringing new development to market and to patients are crucial to the development of a Knowledge Based Bio Economy. Bio, Pharma and related industry sector licensing executives come to the TTS to meet, build relationships, and do business with leading universities and research institutes.
TTS Ltd now provides the TTS Global Initiative, a global series of summits that offer a networking platform for the dissemination and deliberation of problems and solutions, available methods and processes; the TTS Innovation Bank hosting a wealth of technology offerings and ultimately the complete provision of access to business resources that underpin the commercialization of innovative technology. The TTS Global Initiative is of importance to entrepreneurial researchers & innovators, university, institute, clinic and hospital Tech Transfer Offices, corporations, and investors alike, allowing them to successfully network, collaborate and form partnerships that can help drive forward innovative technologies to the markets. There is no other major initiative which specifically focuses on these groups and brings so many key representatives together from research, start-ups and industry.
The creation of a network of technology transfer professionals, early stage start-ups, leading researchers and corporate biotechnology stakeholders to help commercialise the ever increasing amount of innovative biotechnology in our society.
The constructive deliberation and debate that the TTS Global Initiative provides, coupled with exclusive networking opportunities with key biotechnology stakeholders, will enable the process of biotechnology innovation and commercialisation to become better understood and applied and subsequently deliver that which we all strive to achieve; the commercialisation of biotechnological innovation.
• Build the most dynamic global biotechnology innovation specialist network of all key stakeholder groups
• Be recognised as the premier such community, network and organisation for entrepreneurs, angel investors, government funding bodies, investors, corporations, R&D experts and policy makers
• Deliver global Summits that provide the required environment for those interested in biotech IP, tech transfer, innovation and commercialisation, either directly or indirectly, to meet and network for the benefit of real business development and ultimately future commercialisation.
• Provide the TTS Innovation Bank to facilitate and showcase technology offerings from around the world in the life sciences / healthcare / biotechnology sectors.
September 27, 2012
Chris Austin, Director, NIH National Center for Advancing Translational Science (NCATS) to deliver a keynote presentation at TTS North America 2012.
September 24, 2012
We are pleased to confirm the Steven Tregay, CEO of Forma Therapeutics, will deliver a keynote presentation at the TTS North America 2012.
Founded in 2008 and… more
June 13, 2012
The Licensing Executive Society (LES) Britain & Ireland has officially become a Partner of the Global Tech Transfer Initiative, and will be present at the TTS… more
December 6, 2013